Replimune, which suffered significant losses on July 22, 2025, after the FDA rejected its skin cancer treatment, is one of the top gainers in premarket trading today.
The following is the list of biotech stocks making big moves in premarket trading today.
Gainers
Replimune Group Inc. (REPL) is up over 56% at $5.87Capricor Therapeutics Inc. (CAPR) is up nearly 22% at $8.22Sarepta Therapeutics Inc. (SRPT) is up nearly 14% at $18.03AtriCure Inc. (ATRC) is up over 10% at $35.05Aclaris Therapeutics Inc. (ACRS) is up nearly 10% at $1.70GRI Bio Inc. (GRI) is up over 9% at $2.15NeurAxis Inc. (NRXS) is up over 8% at $2.85Uniqure NV (QURE) is up more than 7% at $14.70Protagenic Therapeutics Inc. (PTIX) is up nearly 7% at $3.28DiaMedica Therapeutics Inc. (DMAC) is up over 6% at $4.90.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.